These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17240485

  • 21. Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier.
    Guirola M, Urquiza D, Alvarez A, Cannan-Haden L, Caballero E, Guillén G.
    FEMS Immunol Med Microbiol; 2006 Mar; 46(2):169-79. PubMed ID: 16487298
    [Abstract] [Full Text] [Related]

  • 22. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.
    Vaccine; 2005 May 31; 23(29):3762-74. PubMed ID: 15893613
    [Abstract] [Full Text] [Related]

  • 23. Immunization with meningococcal polysaccharide-tetanus toxoid conjugate induces polysaccharide-reactive T cells in mice.
    Muthukkumar S, Stein KE.
    Vaccine; 2004 Mar 12; 22(9-10):1290-9. PubMed ID: 15003659
    [Abstract] [Full Text] [Related]

  • 24. PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine.
    Huang Q, Li D, Kang A, An W, Fan B, Ma X, Ma G, Su Z, Hu T.
    J Control Release; 2013 Nov 28; 172(1):382-389. PubMed ID: 23511718
    [Abstract] [Full Text] [Related]

  • 25. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
    Menéndez T, Santiago-Vispo NF, Cruz-Leal Y, Coizeau E, Garay H, Reyes O, Batista Y, Cobas K, Carmenate T, Chinea G, Guillén G.
    Int J Med Microbiol; 2011 Jan 28; 301(1):16-25. PubMed ID: 20708963
    [Abstract] [Full Text] [Related]

  • 26. Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine.
    García-Ojeda PA, Monser ME, Rubinstein LJ, Jennings HJ, Stein KE.
    Infect Immun; 2000 Jan 28; 68(1):239-46. PubMed ID: 10603394
    [Abstract] [Full Text] [Related]

  • 27. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope.
    Michon F, Huang CH, Farley EK, Hronowski L, Di J, Fusco PC.
    Dev Biol (Basel); 2000 Jan 28; 103():151-60. PubMed ID: 11214233
    [Abstract] [Full Text] [Related]

  • 28. Prevention of meningococcal serogroup C disease by NeisVac-C.
    Borrow R, Findlow J.
    Expert Rev Vaccines; 2009 Mar 28; 8(3):265-79. PubMed ID: 19249967
    [Abstract] [Full Text] [Related]

  • 29. Development of meningococcal polysaccharide conjugate vaccine that can elicit long-lasting and strong cellular immune response with hepatitis B core antigen virus-like particles as a novel carrier protein.
    Xu L, Li Z, Su Z, Yang Y, Ma G, Yu R, Zhang S.
    Vaccine; 2019 Feb 08; 37(7):956-964. PubMed ID: 30655174
    [Abstract] [Full Text] [Related]

  • 30. AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.
    Romeu B, González E, Zayas C, Del Campo J, Acevedo R, Cuello M, Valdes Y, Balboa J, Cabrera O, Lastre M, Pérez O.
    Scand J Infect Dis; 2011 Oct 08; 43(10):809-13. PubMed ID: 21671827
    [Abstract] [Full Text] [Related]

  • 31. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B.
    J Infect Dis; 2001 Jan 01; 183(1):97-104. PubMed ID: 11087205
    [Abstract] [Full Text] [Related]

  • 32. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ.
    Contrib Microbiol Immunol; 1989 Jan 01; 10():151-65. PubMed ID: 2479499
    [No Abstract] [Full Text] [Related]

  • 33. Memory B and T cell responses induced by serotype 4 Streptococcus pneumoniae vaccines: longitudinal analysis comparing responses elicited by free polysaccharide, conjugate and carrier.
    Deauvieau F, Dussurgey S, Rossignol D, de Montfort A, Burdin N, Guy B.
    Vaccine; 2009 Dec 11; 28(2):576-82. PubMed ID: 19878751
    [Abstract] [Full Text] [Related]

  • 34. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
    Guirola M, Carmenate T, Menéndez T, Alvarez A, González S, Guillén G.
    J Microbiol Methods; 2006 Apr 11; 65(1):135-43. PubMed ID: 16122825
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger.
    Chippaux JP, Garba A, Ethevenaux C, Campagne G, de Chabalier F, Djibo S, Nicolas P, Ali H, Charrondière M, Ryall R, Bybel M, Schuchat A.
    Vaccine; 2004 Sep 03; 22(25-26):3303-11. PubMed ID: 15308353
    [Abstract] [Full Text] [Related]

  • 36. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines.
    Reddin KM, Crowley-Luke A, Clark SO, Vincent PJ, Gorringe AR, Hudson MJ, Robinson A.
    FEMS Immunol Med Microbiol; 2001 Aug 03; 31(2):153-62. PubMed ID: 11549423
    [Abstract] [Full Text] [Related]

  • 37. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life.
    Diez-Domingo J, Planelles-Cantarino MV, Baldo-Torrenti JM, Ubeda-Sansano I, Jubert-Rosich A, Puig-Barbera J, Gutierrez-Gimeno MV.
    Pediatr Infect Dis J; 2010 Aug 03; 29(8):768-70. PubMed ID: 20375851
    [Abstract] [Full Text] [Related]

  • 38. Surface plasmon resonance analysis of antipolysaccharide antibody specificity: responses to meningococcal group C conjugate vaccines and bacteria.
    García-Ojeda PA, Hardy S, Kozlowski S, Stein KE, Feavers IM.
    Infect Immun; 2004 Jun 03; 72(6):3451-60. PubMed ID: 15155652
    [Abstract] [Full Text] [Related]

  • 39. Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.
    Tunheim G, Naess LM, Acevedo R, Fjeldheim ÅK, Bolstad K, García L, Cardoso D, Aase A, Zayas C, González H, Rosenqvist E, Norheim G.
    Vaccine; 2014 Nov 20; 32(49):6631-8. PubMed ID: 25305564
    [Abstract] [Full Text] [Related]

  • 40. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
    Borrow R, Goldblatt D, Andrews N, Richmond P, Southern J, Miller E.
    J Infect Dis; 2001 Aug 01; 184(3):377-80. PubMed ID: 11443568
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.